Nasal glucagon (LY900018)

LY900018 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nasal glucagon (LY900018), covering 2019-10-08 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus [Phase 3]